Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132881) titled 'Feasibility clinical study on the safety and effectiveness of NaviLoc Vavle in the treatment of aortic valve insufficiency' on Sept. 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Fuwai Central China Cardiovascular Hospital
Condition:
Aortic insufficiency
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Experimental group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=344073
Published by HT Digital Content Services with permission from Health Daily Digest....